Research Overview

Retatrutide

Retatrutide (GLP-3R / triple-receptor agonist)

A triple-hormone-receptor agonist studied as the next step beyond dual-incretin research compounds.

What It Is

Retatrutide is a synthetic peptide engineered to act as an agonist at three receptor systems simultaneously: the GIP receptor, the GLP-1 receptor, and the glucagon receptor. It extends the dual-agonist design principle seen in earlier incretin research compounds by adding glucagon-receptor activity as a third studied pathway.

Published phase 2 trial data in major peer-reviewed journals has characterized its receptor pharmacology, positioning it as one of the most closely watched compounds in current triple-agonist metabolic research.

Mechanism in the Research Literature

The literature describes retatrutide's mechanism as balanced agonism across the GIP, GLP-1, and glucagon receptors. Research has focused specifically on what the added glucagon-receptor activity contributes beyond dual-incretin agonism, since glucagon signaling engages energy-expenditure pathways that are mechanistically distinct from the insulinotropic effects of GIP and GLP-1 alone.

As with tirzepatide, retatrutide's design includes structural modifications intended to extend its pharmacokinetic half-life, a common engineering approach across this peptide class that researchers account for when designing sampling schedules for in vivo studies.

Why Purity Verification Matters Here

Engaging three separate receptor systems means retatrutide's research utility depends entirely on the intact molecule presenting the correct binding domains for all three targets. Any synthesis impurity that affects even one domain can distort the balance of receptor engagement being studied, without necessarily showing up as an obvious purity problem. This is precisely the scenario independent, lot-matched HPLC and mass-spec testing is designed to catch before it reaches a research bench.

Third-party tested. Lot-matched. No exceptions.

Every unrl batch is characterized by independent third-party testing before it ships, not just an in-house spec sheet. Each Certificate of Analysis is tied to the lot number printed on the vial, so what you're holding matches a specific, published result rather than a generic average.

Independent lab, not manufacturer self-testing
HPLC purity + mass spectrometry identity confirmation
Lot-specific CoA, matched to the vial in hand
Published and searchable in the public COA library

View the COA Library

Research Use Only

This page is provided for research and educational purposes only. The compound discussed is a research reference standard, not a dietary supplement, drug, or article for human or veterinary use. Nothing on this page is medical advice, dosing guidance, or a claim of safety or efficacy. No statement has been evaluated by the FDA.

Quick Reference